Press release – For immediate release – 8:30 am CEST
Portzamparc Groupe BNP Paribas initiates the coverage of Median Technologies with a “Strong Buy” recommendation
Median Technologies (Euronext Growth – ALMDT) announces today the publication of an initiation report by Portzamparc Groupe BNP Paribas, a French leading group covering brokerage for Individual and institutional investors, and financial operations for corporate and Institutional clients.
In the initiation report published on July 20, 2023, Portzamparc Groupe BNP Paribas initiates the coverage of the stock with a Strong Buy recommendation.
About Portzamparc Groupe BNP Paribas: Portzamparc’s offering is built around three areas of expertise: support for private and institutional investors on the stock market, with a transaction volume of nearly €9 billion; third-party asset management, with €4 billion in assets under management; and market operations for SMEs/ETIs, with undisputed leadership in IPOs. From IPOs to financial analysis, Portzamparc’s experience and reputation make it the benchmark for mid-cap companies.
Pioneering innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to enhance the accuracy of early cancer diagnoses and treatments. Median’s offerings include iCRO, which provides medical image analysis and management in oncology trials, and eyonis™, an AI/ML tech-based suite of software as medical devices (SaMD). Median empowers biopharmaceutical entities and clinicians to advance patient care and expedite the development of novel therapies. The French-based company, with a presence in the U.S. and China, trades on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also eligible for the French SME equity savings plan scheme (PEA-PME). For more information, visit